Quantitatively Accounting for Protein Reorganization in Computer-Aided Drug Design
The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Structure-based drug design frequently operates under the assumption that a single holo structure is relevant. However, a large number of crystallographic examples clearly show that multiple conformations are possible. In those cases, the protein reorganization free energy must be known to accurately predict binding free energies for ligands. Only then can the energetic preference among these multiple protein conformations be utilized to design ligands with stronger binding potency and selectivity. Here, we present a computational method to quantify these protein reorganization free energies. We test it on two retrospective drug design cases, Abl kinase and HSP90, and illustrate how alternative holo conformations can be derisked and lead to large boosts in affinity. This method will allow computer-aided drug design to better support complex protein targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FEP+ has been demonstrated to calculate both protein residue pKa values and free energies between different receptor conformations with high accuracy [37,38].”
From Robust prediction of relative binding energies for protein-protein complex mutations using free energy perturbation calculations (2024) · cites this paper as [38]
In the citing paper
“Specifically, protein reorganization FEP has been applied successfully to account for changes in loop conformation in absolute binding FEP calculations with protein-ligand complexes [38].”
From Robust prediction of relative binding energies for protein-protein complex mutations using free energy perturbation calculations (2024) · cites this paper as [38]
Citations
Cites
Improved side‐chain torsion potentials for the Amber ff99SB protein force field
Lindorff‐Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J. L., Dror, R. O., & Shaw, D. E. (2010) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.22711 · Cited by 6,134
Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9644-8 · Cited by 6,006
The Energy Landscapes and Motions of Proteins
Frauenfelder, H., Sligar, S. G., & Wolynes, P. G. (1991) · Science · doi:10.1126/science.1749933 · Cited by 3,250
High-Temperature Equation of State by a Perturbation Method. I. Nonpolar Gases
Zwanzig, R. W. (1954) · The Journal of Chemical Physics · doi:10.1063/1.1740409 · Cited by 3,066
A comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427
Application of a Theory of Enzyme Specificity to Protein Synthesis
Koshland, D. E. (1958) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.44.2.98 · Cited by 2,396
The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1
Hanks, S. K., & Hunter, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768349 · Cited by 2,318
Wang, E., Sun, H., Wang, J., Wang, Z., Liu, H., Zhang, J. Z. H., & Hou, T. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00055 · Cited by 2,232
The role of dynamic conformational ensembles in biomolecular recognition
Boehr, D. D., Nussinov, R., & Wright, P. E. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.232 · Cited by 2,008
OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space
Lu, C., Wu, C., Ghoreishi, D., Chen, W., Wang, L., Damm, W., Ross, G. A., Dahlgren, M. K., Russell, E., Von Bargen, C. D., et al. (2021) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.1c00302 · Cited by 2,005
Self-citationEinfluss der Configuration auf die Wirkung der Enzyme
Fischer, E. (1894) · Berichte der deutschen chemischen Gesellschaft · doi:10.1002/cber.18940270364 · Cited by 1,835
Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Three-dimensional structure of the tyrosine kinase c-Src
Xu, W., Harrison, S. C., & Eck, M. J. (1997) · Nature · doi:10.1038/385595a0 · Cited by 1,418
Stebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., & Pavletich, N. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80203-2 · Cited by 1,364
Wang, L., Wu, Y., Deng, Y., Kim, B., Pierce, L., Krilov, G., Lupyan, D., Robinson, S., Dahlgren, M. K., Greenwood, J., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/ja512751q · Cited by 1,313
Self-citationTarget identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
Crystal structure of the tyrosine kinase domain of the human insulin receptor
Hubbard, S. R., Wei, L., & Hendrickson, W. A. (1994) · Nature · doi:10.1038/372746a0 · Cited by 1,080
The Process of Structure-Based Drug Design
Anderson, A. C. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.09.002 · Cited by 939
Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.021 · Cited by 886
How Robust Are Protein Folding Simulations with Respect to Force Field Parameterization?
Piana, S., Lindorff-Larsen, K., & Shaw, D. E. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.03.051 · Cited by 795
Tokarski, J. S., Newitt, J. A., Chang, C. Y. J., Cheng, J. D., Wittekind, M., Kiefer, S. E., Kish, K., Lee, F. Y. F., Borzillerri, R., Lombardo, L. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4187 · Cited by 700
Virtual Screening Strategies in Drug Discovery: A Critical Review
Lavecchia, A., & Giovanni, C. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990001 · Cited by 686
Systematic Validation of Protein Force Fields against Experimental Data
Lindorff-Larsen, K., Maragakis, P., Piana, S., Eastwood, M. P., Dror, R. O., & Shaw, D. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032131 · Cited by 645
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors
Roskoski, R. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.01.003 · Cited by 607
Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation
Yamaguchi, H., & Hendrickson, W. A. (1996) · Nature · doi:10.1038/384484a0 · Cited by 492
Self-guided Langevin dynamics simulation method
Wu, X., & Brooks, B. R. (2003) · Chemical Physics Letters · doi:10.1016/j.cplett.2003.10.013 · Cited by 452
Noé, F., Horenko, I., Schütte, C., & Smith, J. C. (2007) · The Journal of Chemical Physics · doi:10.1063/1.2714539 · Cited by 393
Predicting Binding Free Energies: Frontiers and Benchmarks
Mobley, D. L., & Gilson, M. K. (2017) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-070816-033654 · Cited by 390
Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy
Rossari, F., Minutolo, F., & Orciuolo, E. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0624-2 · Cited by 371
Defining a new nomenclature for the structures of active and inactive kinases
Modi, V., & Dunbrack, R. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814279116 · Cited by 367
Kinetics of protein–ligand unbinding: Predicting pathways, rates, and rate-limiting steps
Tiwary, P., Limongelli, V., Salvalaglio, M., & Parrinello, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424461112 · Cited by 347
Reweighted autoencoded variational Bayes for enhanced sampling (RAVE)
Ribeiro, J. M. L., Bravo, P., Wang, Y., & Tiwary, P. (2018) · The Journal of Chemical Physics · doi:10.1063/1.5025487 · Cited by 330
Advancing Drug Discovery through Enhanced Free Energy Calculations
Abel, R., Wang, L., Harder, E. D., Berne, B. J., & Friesner, R. A. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.7b00083 · Cited by 327
Self-citationRandom walk in orthogonal space to achieve efficient free-energy simulation of complex systems
Zheng, L., Chen, M., & Yang, W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810631106 · Cited by 310
Large-Scale Assessment of Binding Free Energy Calculations in Active Drug Discovery Projects
Schindler, C. E. M., Baumann, H., Blum, A., Böse, D., Buchstaller, H.-P., Burgdorf, L., Cappel, D., Chekler, E., Czodrowski, P., Dorsch, D., et al. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00900 · Cited by 303
Protein conformational flexibility modulates kinetics and thermodynamics of drug binding
Amaral, M., Kokh, D. B., Bomke, J., Wegener, A., Buchstaller, H. P., Eggenweiler, H. M., Matias, P., Sirrenberg, C., Wade, R. C., & Frech, M. (2017) · Nature Communications · doi:10.1038/s41467-017-02258-w · Cited by 291
Zhou, T., Commodore, L., Huang, W., Wang, Y., Thomas, M., Keats, J., Xu, Q., Rivera, V. M., Shakespeare, W. C., Clackson, T., et al. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.01054.x · Cited by 287
Young, M. A., Shah, N. P., Chao, L. H., Seeliger, M., Milanov, Z. V., Biggs, W. H., Treiber, D. K., Patel, H. K., Zarrinkar, P. P., Lockhart, D. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2788 · Cited by 276
Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 Isoforms
Wright, L., Barril, X., Dymock, B., Sheridan, L., Surgenor, A., Beswick, M., Drysdale, M., Collier, A., Massey, A., Davies, N., et al. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.033 · Cited by 268
Thermodynamics of cavity formation in water. A molecular dynamics study
Postma, J. P. M., Berendsen, H. J. C., & Haak, J. R. (1982) · Faraday Symposia of the Chemical Society · doi:10.1039/fs9821700055 · Cited by 253
Unbinding Kinetics of a p38 MAP Kinase Type II Inhibitor from Metadynamics Simulations
Casasnovas, R., Limongelli, V., Tiwary, P., Carloni, P., & Parrinello, M. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b12950 · Cited by 211
Theoretical calculation of relative binding affinity in host-guest systems.
Lybrand, T. P., McCammon, J. A., & Wipff, G. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.833 · Cited by 194
Wang, L., Deng, Y., Knight, J. L., Wu, Y., Kim, B., Sherman, W., Shelley, J. C., Lin, T., & Abel, R. (2013) · Journal of Chemical Theory and Computation · doi:10.1021/ct300911a · Cited by 194
Self-citationThe maximal and current accuracy of rigorous protein-ligand binding free energy calculations
Ross, G. A., Lu, C., Scarabelli, G., Albanese, S. K., Houang, E., Abel, R., Harder, E. D., & Wang, L. (2023) · Communications Chemistry · doi:10.1038/s42004-023-01019-9 · Cited by 178
Self-citationIns and Outs of Kinase DFG Motifs
Treiber, D. K., & Shah, N. P. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.06.001 · Cited by 173
Ovchinnikov, V., Karplus, M., & Vanden‐Eijnden, E. (2011) · The Journal of Chemical Physics · doi:10.1063/1.3544209 · Cited by 136
Accurate Modeling of Scaffold Hopping Transformations in Drug Discovery
Wang, L., Deng, Y., Wu, Y., Kim, B., LeBard, D. N., Wandschneider, D., Beachy, M., Friesner, R. A., & Abel, R. (2016) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.6b00991 · Cited by 136
Self-citationMullard, A. (2022) · Nature Reviews Drug Discovery · doi:10.1038/d41573-022-00001-9 · Cited by 134
Chen, W., Cui, D., Jerome, S. V., Michino, M., Lenselink, E. B., Huggins, D. J., Beautrait, A., Vendome, J., Abel, R., Friesner, R. A., et al. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00013 · Cited by 117
Self-citationCan Morphing Methods Predict Intermediate Structures?
Weiss, D. R., & Levitt, M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.064 · Cited by 114
Crystal Structure of the T315I Mutant of Abl Kinase
Zhou, T., Parillon, L., Li, F., Wang, Y., Keats, J. A., Lamore, S. D., Xu, Q., Shakespeare, W. C., Dalgarno, D. C., & Zhu, X. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00556.x · Cited by 110
Enhancing Water Sampling in Free Energy Calculations with Grand Canonical Monte Carlo
Ross, G. A., Russell, E., Deng, Y., Lu, C. T., Harder, E. D., Abel, R., & Wang, L. (2020) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.0c00660 · Cited by 107
Self-citationGan, W., Yang, S.-C., & Roux, B. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.06.016 · Cited by 94
Sensitivity in Binding Free Energies Due to Protein Reorganization
Lim, N. M., Wang, L., Abel, R., & Mobley, D. L. (2016) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.6b00532 · Cited by 76
Self-citationThe march of structural biology
Campbell, I. D. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm800 · Cited by 75
Ribeiro, J. M. L., & Tiwary, P. (2018) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.8b00869 · Cited by 75
Wang, J., Shao, Q., Xu, Z., Liu, Y., Yang, Z., Cossins, B. P., Jiang, H., Chen, K., Shi, J., & Zhu, W. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp4105129 · Cited by 70
Predicting Binding Free Energies of PDE2 Inhibitors. The Difficulties of Protein Conformation
Pérez‐Benito, L., Keränen, H., van Vlijmen, H., & Tresadern, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-23039-5 · Cited by 58
The Activation of c-Src Tyrosine Kinase: Conformational Transition Pathway and Free Energy Landscape
Fajer, M., Meng, Y., & Roux, B. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b08409 · Cited by 54
Self-citationPan, A. C., Weinreich, T. M., Shan, Y., Scarpazza, D. P., & Shaw, D. E. (2014) · Journal of Chemical Theory and Computation · doi:10.1021/ct500223p · Cited by 33
Miura, T., Fukami, T. A., Hasegawa, K., Ono, N., Suda, A., Shindo, H., Yoon, D.-O., Kim, S., Na, Y.-J., Aoki, Y., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.001 · Cited by 32
Wang, J., Gu, Y., & Liu, H. (2006) · The Journal of Chemical Physics · doi:10.1063/1.2346681 · Cited by 29
Meshkin, H., & Zhu, F. (2017) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.6b01171 · Cited by 28
Computing the Relative Stabilities and the Per-Residue Components in Protein Conformational Changes
Roy, A., Pérez, A., Dill, K. A., & MacCallum, J. L. (2013) · Structure · doi:10.1016/j.str.2013.10.015 · Cited by 27
Computing conformational free energy by deactivated morphing
Park, S.-H., Lau, A. Y., & Roux, B. (2008) · The Journal of Chemical Physics · doi:10.1063/1.2982170 · Cited by 23
Conformational Free Energy Changes via an Alchemical Path without Reaction Coordinates
He, P., Zhang, B. W., Arasteh, S., Wang, L., Abel, R., & Levy, R. M. (2018) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.8b01851 · Cited by 14
Self-citationStructure of the ABL2/ARG kinase in complex with dasatinib
Ha, B. H., Simpson, M. A., Koleske, A. J., & Boggon, T. J. (2015) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x15004793 · Cited by 10
Protein Loop Conformational Free Energy Changes via an Alchemical Path without Reaction Coordinates
Arasteh, S., Zhang, B. W., & Levy, R. M. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c00778 · Cited by 8
Orndorff, P. B., Phan, S. T. L., Li, K.-H., & van der Vaart, A. (2020) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.0c00403 · Cited by 7
Calculation of Conformational Free Energies with the Focused Confinement Method
van der Vaart, A., Orndorff, P. B., & Phan, S. T. L. (2019) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.9b00590 · Cited by 6
The maximal and current accuracy of rigorous protein-ligand binding free energy calculationsPreprint
Ross, G. A., Lu, C. T., Scarabelli, G., et al. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-p2vpg · Cited by 6
Research works printed but not linked: 1
- Nagar B., 2002, Cancer Res., 62, 4236
Cited by
Wang, Y., Wang, A., Liu, S., Li, L., Liu, Y., Liu, Y., Nie, G., Nie, S., Yao, S., & Yu, H. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.151439 · Cited by 40
Lysozyme stability in various deep eutectic solvents using molecular dynamics simulations
Hebbar, A., Dey, P., & Vatti, A. K. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2275178 · Cited by 35
Enabling structure-based drug discovery utilizing predicted models
Miller, E. B., Hwang, H., Shelley, M. Y., Placzek, A., Rodrigues, J., Suto, R. K., Wang, L., Akinsanya, K., & Abel, R. (2024) · Cell · doi:10.1016/j.cell.2023.12.034 · Cited by 31
Self-citationSampson, J. M., Cannon, D. A., Duan, J., Epstein, J. C. K., Sergeeva, A. P., Katsamba, P. S., Mannepalli, S. M., Bahna, F. A., Adihou, H., Guéret, S. M., et al. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168640 · Cited by 24
Self-citationAI meets physics in computational structure-based drug discovery for GPCRs
Michino, M., Vendôme, J., & Kufareva, I. (2025) · npj Drug Discovery. · doi:10.1038/s44386-025-00019-0 · Cited by 32
Metadata
- Authors
- Fajer, M., Borrelli, K., Abel, R., & Wang, L.
- Affiliations
- Schrodinger (United States) (US)
- Schrodinger Inc., 1540 Broadway, New York, New York 10036, United States
- Corresponding author
- Fajer, Mikolai
- Wang, Lingle
- Venue
- Journal of Chemical Theory and Computation
- Publisher
- American Chemical Society (ACS)
- Published
- 2023-05-23
- Volume
- 19
- Issue
- 11
- Pages
- 3080-3090
- ISSN
- 1549-9618 (ISSN-L)
- 1549-9626
- OpenAlex
- W4377565353
- Cited by
- 18
- References
- 70
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 7 · 2023: 2
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Chemical Theory and Computation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Keywords
- protein conformational heterogeneity, binding free energy prediction, structure-based drug design, c-Abl, HSP90, ligand binding affinity, protein-ligand binding
- MeSH terms
- Binding Sites, Ligands, Protein Binding, Protein Conformation, Retrospective Studies, Drug Design, HSP90 Heat-Shock Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.